At a glance
ClinicalIndex Comparison RecordN/ACompleted· 103 enrolled
Drug / intervention
SYNERGYTM Coronary Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SYNERGY China: A Prospective, Multicenter Trial to Assess the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
In Brief
A clinical study evaluating SYNERGYTM Coronary Stent System for Cardiovascular Diseases. Completed, enrolled 103 participants across 8 sites.
Detailed Summary
Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedJul 2015
Primary CompletionOct 2015
Study CompletionAug 2017
TodayJul 2026
First PostedJul 16, 2015
Enrollment StartMay 1, 2015
Primary CompletionOct 1, 2015
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.0 years ago
Interventions
SYNERGYTM Coronary Stent Systemdevice
SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System